Abstract
The aim of this study was to investigate the correspondence of different biological ageing estimates (i.e. epigenetic age) in blood and muscle tissue and their associations with physical activity (PA), physical function and body composition.
Two independent cohorts were included, whose age span covered adulthood (23–69 years). Whole blood and m. vastus lateralis samples were collected, and DNA methylation analysed. Four different DNA methylation age (DNAmAge) estimates were calculated using genome-wide methylation data and publicly available online tools. A novel muscle-specific methylation age was estimated using the R-package ‘MEAT’. PA was measured with questionnaires and accelerometers. Several tests were conducted to estimate cardiorespiratory fitness and muscle strength. Body composition was estimated by dual-energy X-ray absorptiometry.
DNAmAge estimates from blood and muscle were highly correlated with chronological age, but different age acceleration estimates were weakly associated with each other. The monozygotic twin within-pair similarity of ageing pace was higher in blood (r=0.617–0.824) than in muscle (r=0.523–0.585). Associations of age acceleration estimates with PA, physical function and body composition were weak in both tissues and mostly explained by smoking and sex. The muscle-specific epigenetic clock MEAT was developed to predict chronological age, which may explain why it did not associate with functional phenotypes. The Horvath’s clock and GrimAge were weakly associated with PA and related phenotypes, suggesting that higher PA would be linked to accelerated biological ageing in muscle. This may, however, be more reflective of the low capacity of epigenetic clock algorithms to measure functional muscle ageing than of actual age acceleration.
Based our results, the investigated epigenetic clocks have rather low value in estimating muscle ageing with respect to the physiological adaptations that typically occur due to ageing or PA. Thus, further development of methods is needed to gain further insight into muscle tissue-specific ageing and the underlying biological pathways.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
ES was supported by the Academy of Finland (grant number 260001), the Juho Vainio foundation and the Yrjo Jahnsson foundation. VK was supported by the Academy of Finland (275323). KHP was funded by the Academy of Finland (grant numbers 314383 and 266286), the Academy of Finland Center of Excellence in Research on Mitochondria, Metabolism and Disease (FinMIT; grant number 272376), the Finnish Medical Foundation, the Gyllenberg Foundation, the Novo Nordisk Foundation (grant numbers NNF17OC0027232 and NNF10OC1013354), the Finnish Diabetes Research Foundation, the Finnish Foundation for Cardiovascular Research, Government Research Funds, the University of Helsinki and Helsinki University Hospital. JK was supported by the Academy of Finland (213506, 308248, 312073, 336823), EC FP5 GenomEUtwin, NIH NIH/NHLBI (grant HL104125), EC MC ITN Project EPITRAIN and Sigrid Juselius Foundation. MO was supported by the Academy of Finland (297908 and 251316), EC MC ITN Project EPITRAIN, University of Helsinki Research Funds and Sigrid Juselius Foundation. EKL was supported by the Academy of Finland (309504 and 314181) and the Juho Vainio Foundation.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The FTC data collection and analysis were approved by the ethics committee of the Helsinki University Central Hospital (Dnro 249/E5/01, 270/13/03/01/2008, 154/13/03/00/2011), and the ERMA study was approved by the ethics committee of the Central Finland health care district in 2014 (K-SSHP Dnro 8U/2014). Written informed consent was provided by the participants before the sample collection and PA and functioning measurements.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All twin data used in the current study are located within the Biobank of the National Institute for Health and Welfare, Finland. All the biobanked data are publicly available for use by qualified researchers following a standardized application procedure.
Abbreviations
- BMI
- body mass index, kg/m2
- CpG
- a cytosine nucleotide followed by a guanine nucleotide
- DNAmAge
- DNA methylation age
- ERMA
- Estrogenic Regulation of Muscle Apoptosis study
- FTC
- Finnish twin cohort
- ICC
- Intraclass correlation coefficients
- LTPA
- leisure time physical activity
- MEAT
- muscle epigenetic age test
- MVPA
- a moderate-to-vigorous physical activity
- MZ
- monozygotic
- PA
- physical activity
